API-192 is a first-in-class off-the-shelf allogeneic CAR-NKT cell therapy that expresses dual CARs targeting CD19 and CD20 and armored with soluble IL-15 for improved expansion and persistence API-192 ...
Recognition underscores CrossBridge Bio’s leadership in advancing next-generation dual-payload ADCs toward the clinic. CrossBridge Bio, a biopharmaceutical company pioneering next-generation ...
CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, and supply chain resilience. Notable winners included Corden Pharma for ...
HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has entered into a ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Weave Bio, an AI-native life sciences platform company, announced the public release of its flagship offering, AutoIND, and seed funding of $10M co-led by Innovation ...
Corzo brings a 25+ year successful track record in biopharma, excelling in oncology drug development with Takeda, Sanofi Genzyme, and Eli Lilly Appointment will support bit.bio’s continued scaling and ...
James M. Wilson, MD, PhD, director of the Gene Therapy Program at the University of Pennsylvania, and a co-founder of Passage Bio. Passage Bio, a developer of gene therapies for rare monogenic CNS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback